| 000 | 01618 a2200481 4500 | ||
|---|---|---|---|
| 005 | 20250515203529.0 | ||
| 264 | 0 | _c20110224 | |
| 008 | 201102s 0 0 eng d | ||
| 022 | _a1532-2807 | ||
| 024 | 7 |
_a10.1007/s12253-009-9240-3 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aHuang, Qiang | |
| 245 | 0 | 0 |
_aWild Type p53 gene sensitizes rat C6 glioma cells to HSV-TK/ACV treatment in vitro and in vivo. _h[electronic resource] |
| 260 |
_bPathology oncology research : POR _cDec 2010 |
||
| 300 |
_a509-14 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_aAcyclovir _xpharmacokinetics |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAntineoplastic Agents _xpharmacokinetics |
| 650 | 0 | 4 | _aApoptosis |
| 650 | 0 | 4 | _aCell Line |
| 650 | 0 | 4 | _aCell Line, Tumor |
| 650 | 0 | 4 |
_aCell Survival _xdrug effects |
| 650 | 0 | 4 | _aCombined Modality Therapy |
| 650 | 0 | 4 | _aDrug Synergism |
| 650 | 0 | 4 |
_aGanciclovir _xpharmacokinetics |
| 650 | 0 | 4 | _aGenes, p53 |
| 650 | 0 | 4 |
_aGenetic Therapy _xmethods |
| 650 | 0 | 4 |
_aGlioma _xenzymology |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aIn Situ Nick-End Labeling |
| 650 | 0 | 4 | _aMagnetic Resonance Imaging |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aRats |
| 650 | 0 | 4 | _aRats, Sprague-Dawley |
| 650 | 0 | 4 |
_aSimplexvirus _xenzymology |
| 650 | 0 | 4 |
_aThymidine Kinase _xbiosynthesis |
| 700 | 1 | _aXia, Zhibo | |
| 700 | 1 | _aYou, Yongping | |
| 700 | 1 | _aPu, Peiyu | |
| 773 | 0 |
_tPathology oncology research : POR _gvol. 16 _gno. 4 _gp. 509-14 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1007/s12253-009-9240-3 _zAvailable from publisher's website |
| 999 |
_c19461493 _d19461493 |
||